Pregnant Woman in Outcomes with Prosthetic Heart Valves
The effective control of anti-factor Xa activity reduced thrombotic events. However, the persistently high incidence of postpartum hemorrhagic complications suggests a need to reassess anticoagulant therapy regimens, lower target levels of anti-Xa, and reduce INR levels for discontinuing heparin bridge therapy. Despite the heightened mortality risk in MVP patients, our study cohort did not have any mortality cases, which contrasts with findings from other registries.
Authors
- D.А. Kudlаy (ORCID: https://orcid.org/0000-0003-1878-4467)
- Анна Старшинова (ORCID: https://orcid.org/0000-0002-9023-6986)
- U Shadrina (ORCID: https://orcid.org/0000-0002-7259-1546)
- Т. В. Вавилова (ORCID: https://orcid.org/0000-0001-8537-3639)
- O. B. Irtyuga (ORCID: https://orcid.org/0000-0002-8656-3191)
- A.M. Pozhidaeva (ORCID: https://orcid.org/0000-0002-7126-747X)
- А. Е. Баутин (ORCID: https://orcid.org/0000-0001-5031-7637)
- О. В. Сироткина (ORCID: https://orcid.org/0000-0003-3594-1647)
- Giunai Sefiyeva
- Aigul Nasiridinovna Chynybekova (ORCID: https://orcid.org/0000-0003-2552-3775)
- Ekaterina Stepanovykh (ORCID: https://orcid.org/0000-0002-4043-030X)
Institutions
- Sechenov University (RU)
- Lomonosov Moscow State University (RU)
- Federal Almazov North-West Medical Research Centre (RU)
- Institute of Immunology and Physiology (RU)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2024-11-04
- DOI
- https://doi.org/10.3390/jcdd11110353
- Citations
- 2
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.80